Compare $NGNE vs $ZURA | Chartloom

Compare

$NGNE vs $ZURA

Neurogene Inc · Zura Bio Ltd

NGNE

Neurogene Inc

ZURA

Zura Bio Ltd

Compare $NGNE vs $ZURA

Comparing Neurogene Inc and Zura Bio Ltd

NGNENeurogene Inc

ZURAZura Bio Ltd

NGNENeurogene Inc

Market cap

$521M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

31.0%

52W performance

2.2%

FCF yield

-16.8%

ZURAZura Bio Ltd

Market cap

$380M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-27.9%

52W performance

-7.8%

FCF yield

-20.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NGNE

ZURA

Detailed metrics comparison

NGNE

Neurogene Inc

ZURA

Zura Bio Ltd

Market Cap

NGNE$521M

ZURA$380M

Enterprise Value

NGNE$409M

ZURA$175M

Price

NGNE$26.40

ZURA$4.00

P/E Ratio

NGNEN/A

ZURAN/A

P/S Ratio

NGNE0.00x

ZURA0.00x

EV/Sales

NGNE0.00x

ZURA0.00x

EV/EBITDA

NGNE0.00x

ZURA0.00x

P/B Ratio

NGNE2.36x

ZURA1.98x

P/FCF Ratio

NGNEN/A

ZURAN/A

EV/FCF

NGNE-4.66x

ZURA-2.25x

PEG Ratio

NGNEN/A

ZURAN/A

Forward P/E (NTM)

NGNEN/A

ZURAN/A

Forward P/S (NTM)

NGNEN/A

ZURAN/A

Revenue (TTM)

NGNE$0

ZURA$0

Revenue Growth (YoY)

NGNEN/A

ZURAN/A

Forward Rev Growth

NGNE127.3%

ZURA133.3%

Gross Margin (TTM)

NGNE0.0%

ZURA0.0%

Operating Margin (TTM)

NGNE0.0%

ZURA0.0%

EBITDA Margin (TTM)

NGNE0.0%

ZURA0.0%

Net Margin (TTM)

NGNE0.0%

ZURA0.0%

FCF Margin (TTM)

NGNEN/A

ZURAN/A

Net Income (TTM)

NGNE$-46M

ZURA$-116M

FCF (TTM)

NGNE$-88M

ZURA$-78M

EPS (TTM)

NGNE$0.00

ZURA-$0.92

ROE (TTM)

NGNE-2527.0%

ZURA-5445.0%

ROA (TTM)

NGNE-2325.0%

ZURA-4853.0%

ROIC (TTM)

NGNE-2527.0%

ZURA-5445.0%

Cash

NGNE$112M

ZURA$205M

Debt

NGNE$8K

ZURA$0

Net Cash/Debt

NGNE$112M

ZURA$205M

Current Ratio (TTM)

NGNE10.64x

ZURA12.90x

Quick Ratio (TTM)

NGNE10.53x

ZURA12.57x

Debt/Equity (TTM)

NGNE0.00x

ZURA0.00x

Debt/Assets (TTM)

NGNE0.0%

ZURA0.0%

Interest Coverage (TTM)

NGNEN/A

ZURAN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

ZURA0.00x

Beta

NGNE1.71

ZURA-0.03

52W Performance

NGNE2.2%

ZURA-7.8%

YTD Performance

NGNE31.0%

ZURA-27.9%

% from 52W High

NGNE-39.5%

ZURA-46.2%

% from 52W Low

NGNE65.7%

ZURA27.0%

Asset Turnover (TTM)

NGNE0.00x

ZURA0.00x

FCF Yield (TTM)

NGNE-16.8%

ZURA-20.4%

Earnings Yield (TTM)

NGNE-8.8%

ZURA-30.6%

Dividend Yield (TTM)

NGNEN/A

ZURAN/A

Rule of 40

NGNE0.0

ZURA0.0

EV/GP/RG

NGNEN/A

ZURAN/A

Ticker research

View NGNE research View ZURA research

Metric	NGNE Neurogene Inc	ZURA Zura Bio Ltd
Market & Valuation
Market Cap	$521M	$380M
Enterprise Value	$409M	$175M
Price	$26.40	$4.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.66x	-2.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	127.3%	133.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-46M	$-116M
FCF (TTM)	$-88M	$-78M
EPS (TTM)	$0.00	-$0.92
ROE (TTM)	-2527.0%	-5445.0%
ROA (TTM)	-2325.0%	-4853.0%
ROIC (TTM)	-2527.0%	-5445.0%
Financial Health
Cash	$112M	$205M
Debt	$8K	$0
Net Cash/Debt	$112M	$205M
Current Ratio (TTM)	10.64x	12.90x
Quick Ratio (TTM)	10.53x	12.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	-0.03
52W Performance	2.2%	-7.8%
YTD Performance	31.0%	-27.9%
% from 52W High	-39.5%	-46.2%
% from 52W Low	65.7%	27.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.8%	-20.4%
Earnings Yield (TTM)	-8.8%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View ZURA research

Valuation

P/S Ratio

NGNE

0.00x

ZURA

0.00x

EV/FCF

NGNE

-4.66x

ZURA

-2.25x

Growth & revenue

Forward Revenue Growth

ZURA

133.3%

NGNE

127.3%

Profitability & performance

Gross Margin

NGNE

0.0%

ZURA

0.0%

ROE

NGNE

-2527.0%

ZURA

-5445.0%

FCF Yield %

NGNE

-16.8%

ZURA

-20.4%

52-Week Performance

NGNE

2.2%

ZURA

-7.8%

Detailed metrics comparison

NGNE

Neurogene Inc

ZURA

Zura Bio Ltd

Market Cap

NGNE$521M

ZURA$380M

Enterprise Value

NGNE$409M

ZURA$175M

Price

NGNE$26.40

ZURA$4.00

P/E Ratio

NGNEN/A

ZURAN/A

P/S Ratio

NGNE0.00x

ZURA0.00x

EV/Sales

NGNE0.00x

ZURA0.00x

EV/EBITDA

NGNE0.00x

ZURA0.00x

P/B Ratio

NGNE2.36x

ZURA1.98x

P/FCF Ratio

NGNEN/A

ZURAN/A

EV/FCF

NGNE-4.66x

ZURA-2.25x

PEG Ratio

NGNEN/A

ZURAN/A

Forward P/E (NTM)

NGNEN/A

ZURAN/A

Forward P/S (NTM)

NGNEN/A

ZURAN/A

Revenue (TTM)

NGNE$0

ZURA$0

Revenue Growth (YoY)

NGNEN/A

ZURAN/A

Forward Rev Growth

NGNE127.3%

ZURA133.3%

Gross Margin (TTM)

NGNE0.0%

ZURA0.0%

Operating Margin (TTM)

NGNE0.0%

ZURA0.0%

EBITDA Margin (TTM)

NGNE0.0%

ZURA0.0%

Net Margin (TTM)

NGNE0.0%

ZURA0.0%

FCF Margin (TTM)

NGNEN/A

ZURAN/A

Net Income (TTM)

NGNE$-46M

ZURA$-116M

FCF (TTM)

NGNE$-88M

ZURA$-78M

EPS (TTM)

NGNE$0.00

ZURA-$0.92

ROE (TTM)

NGNE-2527.0%

ZURA-5445.0%

ROA (TTM)

NGNE-2325.0%

ZURA-4853.0%

ROIC (TTM)

NGNE-2527.0%

ZURA-5445.0%

Cash

NGNE$112M

ZURA$205M

Debt

NGNE$8K

ZURA$0

Net Cash/Debt

NGNE$112M

ZURA$205M

Current Ratio (TTM)

NGNE10.64x

ZURA12.90x

Quick Ratio (TTM)

NGNE10.53x

ZURA12.57x

Debt/Equity (TTM)

NGNE0.00x

ZURA0.00x

Debt/Assets (TTM)

NGNE0.0%

ZURA0.0%

Interest Coverage (TTM)

NGNEN/A

ZURAN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

ZURA0.00x

Beta

NGNE1.71

ZURA-0.03

52W Performance

NGNE2.2%

ZURA-7.8%

YTD Performance

NGNE31.0%

ZURA-27.9%

% from 52W High

NGNE-39.5%

ZURA-46.2%

% from 52W Low

NGNE65.7%

ZURA27.0%

Asset Turnover (TTM)

NGNE0.00x

ZURA0.00x

FCF Yield (TTM)

NGNE-16.8%

ZURA-20.4%

Earnings Yield (TTM)

NGNE-8.8%

ZURA-30.6%

Dividend Yield (TTM)

NGNEN/A

ZURAN/A

Rule of 40

NGNE0.0

ZURA0.0

EV/GP/RG

NGNEN/A

ZURAN/A

Ticker research

View NGNE research View ZURA research

Metric	NGNE Neurogene Inc	ZURA Zura Bio Ltd
Market & Valuation
Market Cap	$521M	$380M
Enterprise Value	$409M	$175M
Price	$26.40	$4.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.66x	-2.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	127.3%	133.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-46M	$-116M
FCF (TTM)	$-88M	$-78M
EPS (TTM)	$0.00	-$0.92
ROE (TTM)	-2527.0%	-5445.0%
ROA (TTM)	-2325.0%	-4853.0%
ROIC (TTM)	-2527.0%	-5445.0%
Financial Health
Cash	$112M	$205M
Debt	$8K	$0
Net Cash/Debt	$112M	$205M
Current Ratio (TTM)	10.64x	12.90x
Quick Ratio (TTM)	10.53x	12.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	-0.03
52W Performance	2.2%	-7.8%
YTD Performance	31.0%	-27.9%
% from 52W High	-39.5%	-46.2%
% from 52W Low	65.7%	27.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.8%	-20.4%
Earnings Yield (TTM)	-8.8%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View ZURA research